Reata Pharmaceuticals, Inc.
METHODS OF TREATING ALPORT SYNDROME USING BARDOXOLONE METHYL OR ANALOGS THEREOF
Last updated:
Abstract:
The present invention provides methods of treating or preventing Alport syndrome in a patients in need thereof using bardoxolone methyl or analogs thereof, and/or improving the kidney function of patients who have been diagnosed with Alport syndrome.
Status:
Application
Type:
Utility
Filling date:
11 Feb 2021
Issue date:
3 Jun 2021